Ulcerative Colitis

VTX002-201

Clinical Research Study

Are you an adult with moderate to severe Ulcerative Colitis

currently experiencing symptoms?

If yes, you may qualify for this clinical trial.

Sign up today to see if you qualify for this study.

VTX002-201 UC Clinical Study Signup Form

Your Name*
First Last
Email Address*
Phone Number*
Hidden
Phone Number*
Location*
ZIP Code
Do you believe that you meet the criteria required to participate in this clinical trial? (Described under the "Can You Participate" section of this webpage)*
- Yes, I believe I meet the criteria required to participate in this clinical trial
- No, I do not believe I meet the criteria required to participate in this clinical trial
Your Comments/Questions
Comments
This field is for validation purposes and should be left unchanged.

About the VTX002-201 UC Study

Study Name: VTX002-201 (Moderate to Severe UC)

Primary Investigator: Jacob Karr, MD
Study Site: Combined Gastro Research
Location: Lafayette, LA

Ulcerative Colitis occurs when the body’s natural immune system attacks the cells and tissues in the large intestine. Several medications are available to doctors for treating patients with Ulcerative Colitis. However, not all patients respond to the available treatments and some may experience side effects.

VTX002-201 is a clinical trial for patients with moderately to severely active Ulcerative Colitis. The goal of this trial is to evaluate the safety and efficacy of an investigational study drug.

The investigational study drug (VTX002) in this study is:

Taken orally in a tablet form, and
Is tested in people who have not responded well to conventional treatment, like corticosteriods, or biologics.

Can you participate?

A study doctor will need to review your medical history and carry out some additional health checks before deciding whether this study is right for you. You may be able to take part in the VTX002-201 Study if you:

Are 18 years of age or older
Have moderate to severely active Ulcerative Colitis
Have been diagnosed with Ulcerative Colitis at least 3 months prior to screening for this clinical trial

If you would like more information about the VTX002-201 Ulcerative Colitis Clinical Study, please fill out the VTX002-201 UC Clinical Study Signup Form on this page. All information collected will follow federal regulations called HIPAA while protecting your privacy.

What is a clinical research study?

A clinical research study is a medical investigation that is designed to answer specific questions about potential new drugs (called “investigational drugs”). These questions may include how safe and effective an investigational drug is for use in a particular condition or disease.

Every medication that you have been prescribed by a doctor will have undergone rigorous testing in clinical research studies. Without clinical research studies, there would be no real medical advances and no new treatment options would become available.

Taking part in a clinical research study is a big decision and your participation is voluntary. It is important that you understand what participation will involve before you agree to take part.